Table 2 CI of cardiovascular risk... | American Society of Hematology

Table 2

CI of cardiovascular risk factors after HCT

	Entire cohort		Autologous HCT		Allogeneic HCT		P*
	At risk	CI, %	At risk	CI, %	At risk	CI, %	P*
Hypertension
Baseline, at HCT	1885	17.8	1079	22.3	806	11.4
1 y	1885	28.4	1079	24.3	806	33.9
5 y	955	33.7	581	28.7	374	40.3
10 y	232	37.7	139	32.0	138	45.3	< .01
Diabetes
Baseline, at HCT	1885	7.6	1079	8.3	806	5.3
1 y	1885	10.8	1079	9.9	806	11.9
5 y	1242	15.1	705	13.4	537	17.5
10 y	331	18.1	176	15.9	155	20.9	< .01
Dyslipidemia
Baseline, at HCT	1885	18.5	1079	22.8	806	12.5
1 y	1885	33.6	1079	31.3	806	36.6
5 y	812	40.2	475	38.8	337	45.0
10 y	168	46.7	98	43.3	70	50.5	< .01
Multiple (≥ 2)
Baseline, at HCT	1885	8.6	1079	11.9	806	4.2
1 y	1885	16.1	1079	13.1	806	20.0
5 y	1091	25.0	644	20.7	447	30.7
10 y	263	31.4	154	26.3	109	38.1	< .01

	Entire cohort		Autologous HCT		Allogeneic HCT		P*
	At risk	CI, %	At risk	CI, %	At risk	CI, %	P*
Hypertension
Baseline, at HCT	1885	17.8	1079	22.3	806	11.4
1 y	1885	28.4	1079	24.3	806	33.9
5 y	955	33.7	581	28.7	374	40.3
10 y	232	37.7	139	32.0	138	45.3	< .01
Diabetes
Baseline, at HCT	1885	7.6	1079	8.3	806	5.3
1 y	1885	10.8	1079	9.9	806	11.9
5 y	1242	15.1	705	13.4	537	17.5
10 y	331	18.1	176	15.9	155	20.9	< .01
Dyslipidemia
Baseline, at HCT	1885	18.5	1079	22.8	806	12.5
1 y	1885	33.6	1079	31.3	806	36.6
5 y	812	40.2	475	38.8	337	45.0
10 y	168	46.7	98	43.3	70	50.5	< .01
Multiple (≥ 2)
Baseline, at HCT	1885	8.6	1079	11.9	806	4.2
1 y	1885	16.1	1079	13.1	806	20.0
5 y	1091	25.0	644	20.7	447	30.7
10 y	263	31.4	154	26.3	109	38.1	< .01

CI indicates cumulative incidence.

Comparison of autologous versus allogeneic HCT recipients.